Skin findings of Staphylococcus aureus toxin-mediated infection in relation to toxin encoding genes

Pediatric Infectious Disease Journal

Volumn 32, Issue 7, 2013, Pages 727-730

  Courjon, Johan ^a,b,c,d   Hubiche, Thomas ^b   Phan, Alice ^c   Tristan, Anne ^d   Bès, Michele ^d   Vandenesch, François ^d   Etienne, Jerome ^d   Del Giudice, Pascal ^b   Gillet, Yves ^c,d  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Dermatology and Infectious Diseases Unit   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Enterotoxin; Exanthema; Exfoliatin; Staphylococcus aureus; Superantigen; Toxic shock syndrome toxin 1

Indexed keywords

EXFOLIATIN; SUPERANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; GENE CLUSTER; HUMAN; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

BACTERIAL TOXINS; CHILD, PRESCHOOL; CLINICAL MEDICINE; DIAGNOSIS, DIFFERENTIAL; ENTEROTOXINS; EXANTHEMA; EXFOLIATINS; FRANCE; HUMANS; SHOCK, SEPTIC; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 84883256721     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828e89f5     Document Type: Article

References (28)

1. S tevens FA. Staphylococcus aureus infections. N Engl J Med. 1998;339: 520-532.
2. Centers for Disease Control and Prevention. 2012 Nationally Notifiable Diseases and Conditions. Available at: http://wwwn.cdc.gov/nndss/document/ 2012-Case%20Definitions.pdf. Accessed May 15, 2013.
3. T homas D, Chou S, Dauwalder O, et al. Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy. 2007;93:24-41.
4. Jarraud S, Mougel C, Thioulouse J, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70:631-641.
5. Monecke S, Slickers P, Ehricht R. Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol. 2008;53:237-251.
6. Franklin AS. The occurrence of Staphylococcus aureus infection with a scarlatiniform rash. JAMA. 1927;88:1957-1958.
7. D unnet WN, Schallibaum EM. Scarlet-fever-like illness due to staphylococcal infection. Lancet. 1960;2:1227-1229.
8. Feldman CA. Staphylococcal scarlet fever. N Engl J Med. 1962;267: 877-878.
9. McCloskey RV. Scarlet fever and necrotizing fascitis caused by coagulasepositive hemolytic Staphylococcus aureus, phage type 85. Ann Intern Med. 1973;78:85-87.
10. S chlievert PM. Staphylococcal scarlet fever: role of pyrogenic exotoxins. Infect Immun. 1981;31:732-736.
11. L ina G, Gillet Y, Vandenesch F, et al. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis. 1997;25:1369-1373.
12. Wang CC, Lo WT, Hsu CF, et al. Enterotoxin B is the predominant toxin involved in staphylococcal scarlet fever in Taiwan. Clin Infect Dis. 2004;38:1498-1502.
13. Melish ME, Glasgow LA. The staphylococcal scalded-skin syndrome. N Engl J Med. 1970;282:1114-1119.
14. Melish ME, Glasgow LA, Turner MD. The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. J Infect Dis. 1972;125:129-140.
15. Melish ME, Glasgow LA. Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J Pediatr. 1971;78:958-967.
16. Margileth AM. Scalded skin syndrome: Diagnosis, differential diagnosis, and management of 42 children. South Med J. 1975;68:447-454.
17. Hansen RC. Staphylococcal scalded skin syndrome, toxic shock syndrome, and Kawasaki disease. Pediatr Clin North Am. 1983;30:533-544.
18. L adhani S, Joannou CL, Lochrie DP, et al. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev. 1999;12:224-242.
19. Hubiche T, Bes M, Roudiere L, et al. Mild staphylococcal scalded skin syndrome: an underdiagnosed clinical disorder. Br J Dermatol. 2012;166: 213-215.
20. D eVries AS, Lesher L, Schlievert PM et al. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One. 2011;6:e22997.
21. D escloux E, Perpoint T, Ferry T, et al. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis. 2008;27:37-43.
22. S tanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med. 2006;355:1800-1810.
23. R asigade JP, Laurent F, Lina G, et al. Global distribution and evolution of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus, 1981-2007. J Infect Dis. 2010;201:1589-1597.
24. G oering RV, Shawar RM, Scangarella NE, et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J Clin Microbiol. 2008;46: 2842-2847.
25. D ellinger RP, Levy MM, Carlet JM, et al.; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
26. S chlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J Infect Dis. 1984;149:471.
27. S tevens DL, Ma Y, Salmi DB, et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195:202-211.
28. Wessels MR. Streptococcal and Enterococcal infections. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jamesson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 17th ed. New York: McGraw-Hill Medical Publishing Group; 2008:884.